Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data P3 Health Partners Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2022
FY2023
FY2024
FY2024
Revenue
145
491
1,049
1,266
1,500
1,459
Selling and marketing
0.8
1.5
5.1
3.23
1.33
0.92
General and administrative
36.4
53.4
157
122
113
106
Operating expenses
185
520
2,610
1,434
1,821
1,729
Operating income
-39.5
-28.6
-1,561
-168
-321
-270
Other non-operating income
-2.44
-2.82
1.22
-15.8
14.7
-50.8
Pre-tax income
-42
-31.4
-1,560
-184
-306
-321
Income tax
0
0
1.86
2.7
4.39
2.03
Net income to minority interests
-1,291
-129
-175
-175
Net income
-42
-31.4
-270
-57.8
-136
-148
EBITDA
-39.1
-27.8
-1,474
-81.3
-235
-186
EPS, basic
-325.36
-30.53
-46.78
-45.26
EPS, diluted
-325.36
-31.54
-54.06
-45.26
Shares, basic (weighted)
0.83
1.9
2.9
3.27
Shares, diluted (weighted)
0.83
5.89
2.94
3.27
Balance sheet
FY2019
FY2021
FY2022
FY2023
FY2024
FY2024
Cash and equivalents
32.6
36.3
17.5
36.3
38.8
25
Other current assets
5.19
2.64
3.61
14.4
11.4
Total current assets
90.9
101
166
184
133
Property, plant and equipment
6.15
8.84
8.69
5.73
3.37
Lease right-of-use assets
4.73
11.7
15.3
12.9
12.5
Goodwill
0.74
0.87
0
Intangible assets
751
667
574
492
Other non-current assets
16
19.5
19.2
27.8
Total assets
106
877
861
783
657
Accounts payable
11.8
11.5
8.66
8.44
11.7
Accrued liabilities
0
16.6
36.9
29.4
42.4
Short-term debt
0.09
0
0
75.2
45
Total current liabilities
90.6
242
299
496
545
Long-term debt
45.4
94.4
108
109
228
Lease liabilities
3.63
11.5
13.6
11.3
11.5
Other non-current liabilities
0
6.92
9.31
Total liabilities
146
354
427
634
797
Total debt
55.1
94.4
108
109
273
Paid-in capital
0.02
315
509
579
496
Retained earnings
-130
-310
-367
-503
-651
Other comprehensive income
0.45
Shareholders' equity
0.02
5.85
142
75.9
-155
Minority interests
0
Total equity
0.02
5.85
142
75.9
-155
Total liabilities and equity
106
877
861
783
657
Cash flow statement
FY2019
FY2021
FY2022
FY2023
FY2024
FY2024
Net income
-42
-31.4
-1,562
-186
-310
-323
Depreciation and amortization
0.4
0.8
87.3
86.7
86.1
84.2
Stock-based compensation
0.47
0.45
19.4
5.98
5.75
5.58
Deferred income tax
0
0
-1.09
-1.5
Change in receivables
0.42
0.14
Change in payables
6.08
16
-8.1
11.1
Cash from operations
-28.3
-24.6
-126
-76
-110
-91.2
Capital expenditures
-1.45
-2.93
-2.23
-1.83
0
Acquisitions
-0.13
-5.5
0
Cash from investing
-3.86
-3.17
-7.73
-1.83
14.5
0.13
Debt issued
16.2
36.4
15
14.1
88.1
73
Debt repaid
-14.6
-1.49
-3.63
0
-31
-1.14
Cash from financing
63.6
34.8
11.4
100
98.8
72.8
Net change in cash
31.5
7
-122
22.5
3.17
-18.3
Free cash flow
-29.7
-27.5
-128
-77.9
-110
Interest paid
0.56
0.69
5.71
5.81
14.2
13.6
Income taxes paid
0
0.57
5.48
1.44
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.05 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-9.9%
Operating income / revenue.
EBITDA margin
-4.3%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-15.1%
Pre-tax income / revenue.
Net margin
-6.6%
Net income / revenue.
Operating cash flow margin
-8.7%
Cash from operations / revenue.
Return on assets (ROA)
-15.0%
Net income / average total assets.
Stock-based pay / revenue
0.3%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
5.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-2.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
11.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-304.4%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-16.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-9.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
11.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
57.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.46x
Current assets / current liabilities.
Quick ratio
0.05x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.05x
(Cash + short-term investments) / current liabilities.
Debt / assets
18.3%
Total debt / total assets.
Liabilities / assets
79.0%
Total liabilities / total assets.
Net debt
$98.6M
Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital
-$209.2M
Current assets - current liabilities.
Goodwill and intangibles / assets
69.1%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
2.30x
Revenue / average total assets.
Fixed asset turnover
595x
Revenue / average property, plant and equipment.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$29.28
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
0.03x
Market cap / revenue.
EV/Sales
0.10x
Enterprise value / revenue.
Earnings yield
-192.3%
Net income / market cap (the inverse of P/E).
What was P3 Health Partners Inc.'s revenue in fiscal 2024?
P3 Health Partners Inc. reported revenue of $1.46B for fiscal 2024, 2.8% lower than the year before.
Was P3 Health Partners Inc. profitable in fiscal 2024?
No. It reported a net loss of $147.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.